Occupational and Environmental Medicine, Vol 55, 126-131

Dioxin exposure and non-malignant health effects: a mortality study

AC Pesatori, C Zocchetti, S Guercilena, D Consonni, D Turrini and PA Bertazzi
Research Centre for Occupational, Clinical and Environmental Epidemiology (EPOCA), Institute of Occupational Health, University of Milan, Italy.

OBJECTIVE: To investigate, in a population heavily exposed to 2,3,7,8- tetrachlorodibenzo-p-dioxin (TCDD), the possible unusual occurrence of diseases other than cancer. METHODS: Five year extension of the follow up of the cohort involved in the Seveso accident. Soil measurements identified three exposure zones: (A) highest contamination, (B) substantial, and (R) low but higher than background contamination. Blood TCDD measurements, although limited in number, confirmed zone exposure ranking. The 15 year mortality in the exposed cohort was compared with that of a large population in the surrounding non- contaminated territory. Relative risks (RRs) and 95% confidence intervals (95% CIs) were estimated with Poisson regression techniques. RESULTS: The already noted increased occurrence of cardiovascular deaths was confirmed, in particular in zone A, among males for chronic ischaemic heart disease (five deaths, RR 3.0, 95% CI 1.2 to 7.3), and among females for hypertensive disease (three deaths, RR 3.6, 95% CI 1.2 to 11.4) and chronic rheumatic heart disease. Novel findings were the increase of chronic obstructive pulmonary disease, most notably among males in zone A (four deaths, RR 3.7, 95% CI 1.4 to 9.9) and females in zone B (seven deaths, RR 2.4, 95% CI 1.1 to 5.1); and from diabetes, which was significantly increased in females in zone B (13 deaths, RR 1.9, 95% CI 1.1 to 3.2). In zone R, chronic ischaemic heart disease (males and females), hypertension (females), and diabetes (females) showed less pronounced, although significant excesses. CONCLUSIONS: As well as high TCDD exposure, the accident caused a severe burden of strain in the population. Both these factors might have contributed to the noted increased risks (in particular, circulatory and respiratory). The cardiovascular and immune toxicity of TCDD, as well as its complex interaction with the endocrine system, might be relevant to the explanations of these findings. These results, although not conclusive, concur with previous data in suggesting cardiopulmonary and endocrine effects in humans highly exposed to TCDD.

Copyright © 1998 Occupational and Environmental Medicine
CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

• Kim, Y.-H., Shim, Y.-J., Shin, Y.-J., Sul, D., Lee, E., Min, B.-H. (2009). 2,3,7,8-Tetrachlorodibenzo-p-Dioxin (TCDD) Induces Calcium Influx Through T-type Calcium Channel and Enhances Lysosomal Exocytosis and Insulin Secretion in INS-1 Cells. International Journal of Toxicology 28: 151-161 [Abstract] [Full Text]  
• Turunen, A. W, Verkasalo, P. K, Kiviranta, H., Pukkala, E., Jula, A., Mannisto, S., Rasanen, R., Marniemi, J., Vartiainen, T. (2008). Mortality in a cohort with high fish consumption. Int J Epidemiol 37: 1008-1017 [Abstract] [Full Text]  
• Teske, S., Bohn, A. A., Regal, J. F., Neumiller, J. J., Lawrence, B. P. (2005). Activation of the aryl hydrocarbon receptor increases pulmonary neutrophilia and diminishes host resistance to influenza A virus. Am. J. Physiol. Lung Cell. Mol. Physiol. 289: L111-L124 [Abstract] [Full Text]  
• Antkiewicz, D. S., Burns, C. G., Carney, S. A., Peterson, R. E., Heideman, W. (2005). Heart Malformation Is an Early Response to TCDD in Embryonic Zebrafish. Toxicol Sci 84: 368-377 [Abstract] [Full Text]  
• Sommer, R. J., Hume, A. J., Ciak, J. M., VanNostrand, J. J., Friggens, M., Walker, M. K. (2005). Early Developmental 2,3,7,8-Tetrachlorodibenzo-p-Dioxin Exposure Decreases Chick Embryo Heart Chronotropic Response to Isoproterenol but Not to Agents Affecting Signals Downstream of the Beta-Adrenergic Receptor. Toxicol Sci 83: 363-371 [Abstract] [Full Text]  
• Marchand, A., Tomkiewicz, C., Marchandeau, J.-P., Boitier, E., Barouki, R., Garlatti, M. (2005). 2,3,7,8-Tetrachlorodibenzo-p-dioxin Induces Insulin-Like Growth Factor Binding Protein-1 Gene Expression and Counteracts the Negative Effect of Insulin. Mol. Pharmacol. 67: 444-452 [Abstract] [Full Text]  
• Martinez, J. M., Baek, S. J., Mays, D. M., Tithof, P. K., Eling, T. E., Walker, N. J. (2004). EGR1 Is a Novel Target for AhR Agonists in Human Lung Epithelial Cells. Toxicol Sci 82: 429-435 [Abstract] [Full Text]  
• Kern, P. A., Said, S., Jackson, W. G. Jr., Michalek, J. E. (2004). Insulin Sensitivity following Agent Orange Exposure in Vietnam Veterans with High Blood Levels of 2,3,7,8-Tetrachlorodibenzo-p-Dioxin. J. Clin. Endocrinol. Metab. 89: 4665-4672 [Abstract] [Full Text]  
• Martinez, J. M., Afshari, C. A., Bushel, P. R., Masuda, A., Takahashi, T., Walker, N. J. (2002). Differential Toxicogenomic Responses to 2,3,7,8-Tetrachlorodibenzo-p-dioxin in Malignant and Nonmalignant Human Airway Epithelial Cells. Toxicol Sci 69: 409-423 [Abstract] [Full Text]  
• Lockwood, A. H. (2002). Diabetes and Air Pollution. Diabetes Care 25: 1487-1488 [Full Text]  
• Parker, V. G., Mayo, R. M., Logan, B. N., Holder, B. J., Smart, P. T. (2002). Toxins and Diabetes Mellitus: An Environmental Connection?. Diabetes Spectr. 15: 109-112 [Abstract] [Full Text]  
• Steenland, K, Calvert, G, Ketchum, N, Michalek, J (2001). Dioxin and diabetes mellitus: an analysis of the combined NIOSH and Ranch Hand data. Occup. Environ. Med. 58: 641-648 [Abstract] [Full Text]  
• Bertazzi, P. A., Consonni, D., Bachetti, S., Rubagotti, M., Baccarelli, A., Zocchetti, C., Pesatori, A. C. (2001). Health Effects of Dioxin Exposure: A 20-Year Mortality Study. Am J Epidemiol 153: 1031-1044 [Abstract] [Full Text]  
• Cranmer, M., Louie, S., Kennedy, R. H., Kern, P. A., Fonseca, V. A. (2000). Exposure to 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) Is Associated with Hyperinsulinemia and Insulin Resistance. Toxicol Sci 56: 431-436 [Abstract] [Full Text]  
• (2000). Regulations and Advisories. Toxicol Ind Health 16: 173-201